A detailed history of Black Rock Inc. transactions in Argenx Se stock. As of the latest transaction made, Black Rock Inc. holds 1,011,291 shares of ARGX stock, worth $602 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,011,291
Previous 1,047,289 3.44%
Holding current value
$602 Million
Previous $412 Million 5.47%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$356.01 - $451.55 $12.8 Million - $16.3 Million
-35,998 Reduced 3.44%
1,011,291 $435 Million
Q1 2024

May 10, 2024

BUY
$356.95 - $413.29 $19.7 Million - $22.8 Million
55,252 Added 5.57%
1,047,289 $412 Million
Q4 2023

Feb 13, 2024

SELL
$338.91 - $506.01 $54,564 - $81,467
-161 Reduced 0.02%
992,037 $377 Million
Q3 2023

Nov 13, 2023

BUY
$369.35 - $548.43 $148 Million - $220 Million
401,299 Added 67.91%
992,198 $488 Million
Q2 2023

Aug 11, 2023

SELL
$360.14 - $422.58 $28.7 Million - $33.7 Million
-79,771 Reduced 11.89%
590,899 $230 Million
Q1 2023

May 12, 2023

SELL
$334.23 - $403.65 $30.3 Million - $36.6 Million
-90,579 Reduced 11.9%
670,670 $250 Million
Q4 2022

Feb 13, 2023

SELL
$342.17 - $402.31 $14.9 Million - $17.5 Million
-43,470 Reduced 5.4%
761,249 $288 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $6.21 Million - $7.16 Million
18,092 Added 2.3%
804,719 $284 Million
Q2 2022

Aug 12, 2022

BUY
$269.58 - $378.88 $29.8 Million - $41.8 Million
110,396 Added 16.33%
786,627 $298 Million
Q1 2022

May 12, 2022

SELL
$254.45 - $351.06 $13.6 Million - $18.8 Million
-53,579 Reduced 7.34%
676,231 $213 Million
Q4 2021

Feb 10, 2022

SELL
$272.01 - $353.03 $8.75 Million - $11.4 Million
-32,173 Reduced 4.22%
729,810 $256 Million
Q3 2021

Nov 09, 2021

BUY
$295.0 - $350.58 $33.1 Million - $39.3 Million
112,106 Added 17.25%
761,983 $230 Million
Q2 2021

Aug 11, 2021

BUY
$257.11 - $319.92 $167 Million - $208 Million
649,877 New
649,877 $196 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $32.9B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.